About ENDORISK
Tumor biomarkers
Blood
Imaging
Risk analysis
Quality of life
ENDORISK can help patients and health care professionals in personalized treatment of endometrial carcinoma using: tumor biomarkers, blood, imaging, risk analysis, quality of life.
ENDORISk is a personalized model which can predict the risk of lymph node metastases and survival in patients with endometrial carcinoma. Several diagnostic variables can be used in the model, such as pathology, imaging and tumor markers.
ENDORISK is a Bayesian network. This is a probabilistic model, which means that the model calculates the chance of an outcome for each separate variable. The outcomes in ENDORISK are lymph node metastases and survival.
The model also calculates correlations between variables. This enables the possibility to model and analyse dependent and independent relations between variables. Variables that do not have a high individual predictive quality can have a higher collective predictive quality together with other variables. Another advantage of a Bayesian network is that it is not necessary to input all variables to calculate an outcome.
OUR TEAM
Dr. Hanny Pijnenborg gynecologic oncologist
Radboudumc
Dr. Dorry Boll
gynecologic oncologist
Catharina Ziekenhuis
"De kennis die ik door jarenlang onderzoek op baarmoederkanker heb verzameld geeft mij mogelijkheid om samen met de patiënte een goede balans te vinden in kwaliteit en kwantiteit van leven"
Prof. Rosella Hermens
IQ healthcare
Radboudumc
Professor in personalized oncological integrated care
Dr. Nicole Ezendam
IKNL
Dr. Nicole Visser
pathologist Eurofins/PAMM
Drs. Marike Lombaers
MD - PhD student
Radboudumc
Researching and preparing the implementation of ENDORISK in to clinical practice
Prof. Peter Lucas
UT Twente
Dr. Arjen Hommersom
Open Universiteit Nijmegen
Drs. Jesse Davids
MD-PhD student
Radboudumc
Researching the implementation of ENDORISK in to clinical practice
Pathologists:
Prof. Dr. Koen van de Vijver
Dr. Hans Bulten
Dr. Heidi Küsters-Vandevelde
Radiation oncology:
Casper Reijnen
User-interface:
Prof. dr. Steffen Oeltze-Jafra
Anna Kleinau
Gynaecologie:
Prof. dr. Leon Massuger
Dr. Louis van der Putten
Stephanie Vrede
PARTNERS
We collaborate closely with:
DUTCH HOSPITALS PARTICIPATING IN THE "EVALUATION OF CARE IN ENDOMETRIAL CANCER" STUDY:
Winterswijk
Ede
Nijmegen
Boxmeer
Breda
Den Bosch
Tilburg
Helmond
Maastricht
Doetinchem
Weert
Geldrop
Veldhoven
Eindhoven
Streekziekenhuis Koningin Beatrix
​
Beatrixpark 1, 7101 BN Winterswijk
​
Slingeland Ziekenhuis
​
Kruisbergseweg 25, 7009 BL Doetinchem
​
Radboudumc
Geert Grooteplein Zuid 10, 6525 GA Nijmegen
​
​
Canisius Wilhelmina Ziekenhuis
​
​Weg door Jonkerbos 100, 6532 SZ Nijmegen
Maasziekenhuis Pantein
​
Dokter Kopstraat 1, 5835 DV Beugen
​
Ziekenhuis Gelderse Vallei
​
Willy Brandtlaan 10, 6716 RP Ede
​
Amphia Ziekenhuis
​
Molengracht 21, 4818 CK Breda
​
Jeroen Bosch Ziekenhuis
​
Henri Dunantstraat 1, 5223 GZ 's-Hertogenbosch
​
Elkerliek Ziekenhuis
​
Wesselmanlaan 25, 5707 HA Helmond
​
Elisabeth-TweeSteden Ziekenhuis
​
ETZ Elisabeth
Hilvarenbeekseweg 60, 5022 GC Tilburg
ETZ TweeSteden
Dr. Deelenlaan 5, 5042 AD Tilburg
​
Catharina Ziekenhuis
​
Michelangelolaan 2, 5623 EJ Eindhoven
​
Máxima Medisch Centrum
​
Dominee Theodor Fliednerstraat 1, 5631 BM Eindhoven
​
St. Anna Ziekenhuis
​
Bogardeind 2, 5664 EH Geldrop
​
St. Jans Gasthuis
​
Vogelsbleek 5, 6001 BE Weert
​
Maastricht Universitair Medisch Centrum
​
P. Debyelaan 25, 6229 HX Maastricht
​
EUROPEAN HOSPITALS COLLABORATING WITH ENDORISK PROJECTS:
